122 related articles for article (PubMed ID: 7628064)
1. Pentoxifylline inhibits mediator synthesis in an equine in vitro whole blood model of endotoxemia.
Barton MH; Moore JN
Circ Shock; 1994 Dec; 44(4):216-20. PubMed ID: 7628064
[TBL] [Abstract][Full Text] [Related]
2. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin.
Barton MH; Moore JN; Norton N
Am J Vet Res; 1997 Nov; 58(11):1300-7. PubMed ID: 9361896
[TBL] [Abstract][Full Text] [Related]
3. Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses.
Baskett A; Barton MH; Norton N; Anders B; Moore JN
Am J Vet Res; 1997 Nov; 58(11):1291-9. PubMed ID: 9361895
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin-induced procoagulant activity, eicosanoid synthesis, and tumor necrosis factor production by rat peritoneal macrophages: effect of endotoxin tolerance and glucan.
Moore JN; Cook JA; Morris DD; Halushka PV; Wise WC
Circ Shock; 1990 Jul; 31(3):281-95. PubMed ID: 2113440
[TBL] [Abstract][Full Text] [Related]
5. Effects of tumor necrosis factor blockade on interleukin 6, lactate, thromboxane, and prostacyclin responses in miniature horses given endotoxin.
Cargile JL; MacKay RJ; Dankert JR; Skelley L
Am J Vet Res; 1995 Nov; 56(11):1445-50. PubMed ID: 8585654
[TBL] [Abstract][Full Text] [Related]
6. Endotoxin-induced production of thromboxane and prostacyclin by equine peritoneal macrophages.
Morris DD; Moore JN
Circ Shock; 1987; 23(4):295-303. PubMed ID: 3121207
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline inhibits endotoxin-induced NF-kappa B activation and associated production of proinflammatory cytokines.
Ji Q; Zhang L; Jia H; Xu J
Ann Clin Lab Sci; 2004; 34(4):427-36. PubMed ID: 15648785
[TBL] [Abstract][Full Text] [Related]
8. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
Morris DD; Moore JN
Circ Shock; 1989 Jun; 28(2):149-58. PubMed ID: 2544315
[TBL] [Abstract][Full Text] [Related]
9. Pentoxifylline suppression of tumor necrosis factor gene transcription.
Doherty GM; Jensen JC; Alexander HR; Buresh CM; Norton JA
Surgery; 1991 Aug; 110(2):192-8. PubMed ID: 1858029
[TBL] [Abstract][Full Text] [Related]
10. Endotoxin-induced tumor necrosis factor activity production by equine peritoneal macrophages.
Morris DD; Moore JN; Fischer K; Tarleton RL
Circ Shock; 1990 Mar; 30(3):229-36. PubMed ID: 2178798
[TBL] [Abstract][Full Text] [Related]
11. The effects of pentoxifylline infusion on plasma 6-keto-prostaglandin F1 alpha and ex vivo endotoxin-induced tumour necrosis factor activity in horses.
Barton MH; Ferguson D; Davis PJ; Moore JN
J Vet Pharmacol Ther; 1997 Dec; 20(6):487-92. PubMed ID: 9430774
[TBL] [Abstract][Full Text] [Related]
12. Effect of dose and method of administration of endotoxin on cell mediator release in neonatal calves.
Gerros TC; Semrad SD; Proctor RA; LaBorde A
Am J Vet Res; 1993 Dec; 54(12):2121-7. PubMed ID: 8116949
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of ketoprofen and flunixin meglumine on the in vitro response of equine peripheral blood monocytes to bacterial endotoxin.
Jackman BR; Moore JN; Barton MH; Morris DD
Can J Vet Res; 1994 Apr; 58(2):138-43. PubMed ID: 8004539
[TBL] [Abstract][Full Text] [Related]
14. Delayed thromboxane or tumor necrosis factor-alpha, but not leukotriene inhibition, attenuates prolonged pulmonary hypertension in endotoxemia.
Li JX; Oliver JR; Lu CY; Philips JB
Am J Med Sci; 1995 Sep; 310(3):103-10. PubMed ID: 7668305
[TBL] [Abstract][Full Text] [Related]
15. Release of eicosanoids from white blood cells, platelets, smooth muscle cells, and endothelial cells in response to endotoxin and A23187.
Bottoms GD; Johnson M; Ward D; Fessler J; Lamar C; Turek J
Circ Shock; 1986; 20(1):25-34. PubMed ID: 3094976
[TBL] [Abstract][Full Text] [Related]
16. Effects of the second-generation synthetic lipid A analogue E5564 on responses to endotoxin in [corrected] equine whole blood and monocytes.
Figueiredo MD; Moore JN; Vandenplas ML; Sun WC; Murray TF
Am J Vet Res; 2008 Jun; 69(6):796-803. PubMed ID: 18518661
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees.
van Leenen D; van der Poll T; Levi M; ten Cate H; van Deventer SJ; Hack CE; Aarden LA; ten Cate JW
J Immunol; 1993 Aug; 151(4):2318-25. PubMed ID: 8345209
[TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells.
Neuner P; Klosner G; Schauer E; Pourmojib M; Macheiner W; Grünwald C; Knobler R; Schwarz A; Luger TA; Schwarz T
Immunology; 1994 Oct; 83(2):262-7. PubMed ID: 7835945
[TBL] [Abstract][Full Text] [Related]
19. Effect of tumor necrosis factor antibody on synovial fluid cytokine activities in equine antebrachiocarpal joints injected with endotoxin.
Hawkins DL; Cargile JL; MacKay RJ; Broome TA; Skelley LA
Am J Vet Res; 1995 Oct; 56(10):1292-9. PubMed ID: 8928945
[TBL] [Abstract][Full Text] [Related]
20. Effect of tirilazad mesylate (U74006F) on eicosanoid and tumor necrosis factor generation in healthy and endotoxemic neonatal calves.
Semrad SD; Rose ML; Adams JL
Circ Shock; 1993 Aug; 40(4):235-42. PubMed ID: 8375024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
